⌘K

Login Start Free

Home/Filings/4/0001209191-22-039220

4//SEC Filing

Thorp Clay 4

Accession 0001209191-22-039220

CIK 0001539029other

View on SEC.gov Company Profile

Filed

Jun 23, 8:00 PM ET

Accepted

Jun 24, 4:21 PM ET

Size

5.3 KB

Accession

0001209191-22-039220

Insider Transaction Report

Form 4

Period: 2022-06-22

Clearside Biomedical, Inc.CLSD

Director

Transactions

Award
Stock Option (right to buy)
2022-06-22+30,000→ 30,000 total
Exercise: $1.62Exp: 2032-06-21→ Common Stock (30,000 underlying)

Footnotes (1)

[F1]The shares underlying this option vest in full on the earlier of the Issuer's next annual meeting of stockholders or June 22, 2023.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Clearside Biomedical, Inc.

CIK 0001539029

Entity typeother

Related Parties

1

filerCIK 0001592380

Filing Metadata

Form type: 4
Filed: Jun 23, 8:00 PM ET
Accepted: Jun 24, 4:21 PM ET
Size: 5.3 KB

View on SEC.gov